Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-06

FDA Approved: CLOBETASOL PROPIONATE EMOLLIENT FORMULATION — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for a clobetasol propionate emollient formulation from Padagis Israel Pharmaceuticals Ltd, granting approval for the new…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clobetasol propionate emollient formulation (Clobetasol propionate)

Snippet

SUPPL AP for CLOBETASOL PROPIONATE EMOLLIENT FORMULATION (CLOBETASOL PROPIONATE)